ReviewTherapeutic advances in endocrinology and metabolism2019

The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists.

Michaël J B van Baar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.